Clinical Services

Fish oil's role in stopping superbugs

22 June, 2021

Australian scientists have discovered that regular fish oil has the potential to break down superbugs' ability to become resistant to antibiotics.


PanKind initiative sets sights on early detection of pancreatic cancer

21 June, 2021

PanKind has launched the PanKind Early Detection Initiative in a move to strategically work with the research community to improve early diagnosis of pancreatic cancer.


How to avoid dangerous mistakes when responding to anaphylaxis

18 June, 2021

World Allergy Week is seeking to raise awareness of allergies and anaphylaxis, with leading allergy organisations promoting important resources that could save lives.


Promising results from Novavax Phase 3 vaccine trial

18 June, 2021

Novavax's COVID-19 vaccine demonstrated 100% protection against moderate and severe disease, with 90.4% efficacy overall, in the PREVENT-19 Phase 3 trial.


Hope after hip fracture with new registry toolbox launch

17 June, 2021

The Hip Fracture Registry Toolbox is a practical and informative resource that explains the need, and how to best advocate, for the establishment of a national hip fracture registry.


New shingles vaccine now available in Australia

10 June, 2021

GSK Australia has announced that a new vaccine to help protect against shingles in adults aged 50 years and older is now available on the private market in Australia.


Medical volunteers — Street Side Medical Clinic needs you!

03 June, 2021

The mobile medical clinic providing health care to the homeless community in NSW is calling on doctors, nurses, physios and other medical volunteers.


National clinical guidelines released for endometriosis

02 June, 2021

National clinical practice guidelines to diagnose and treat endometriosis have been released, aiming to improve the lives of women living with the debilitating condition.


Personal defibrillator gains CE certification

01 June, 2021

Sydney-based medical device start-up RRR has secured European regulatory approval for its personal automated external defibrillator (AED), CellAED.


PBS-listed progesterone pessary slashes preterm birth risk

31 May, 2021

A vaginal progesterone pessary is reported to be the first progesterone treatment to be reimbursed via the PBS for the prevention of preterm birth.


Metabolic hormone leptin linked to vaccine response

31 May, 2021 by Amy Sarcevic

Reduced levels of the metabolic hormone leptin may be responsible for poor vaccine efficacy among certain individuals, according to a new study.


Infant pain-monitoring device gains international approval

28 May, 2021

The smartphone-based pain assessment application has potential for use in children's hospitals, in postnatal wards, and among parents and other healthcare professionals.


Rising temperatures could lead to more stillbirths, study finds

28 May, 2021

Early research suggests that climate change could lead to more stillbirths.


Last chance for aged-care providers to claim free PainChek licence

20 May, 2021

This fortnight is the last chance for aged-care facilities to participate in the government-subsidised rollout of a complete point-of-care solution for best practice pain management.


Tech restores lives of those in chronic pain

19 May, 2021

The Avalon Study has demonstrated the life-changing benefits of a closed-loop spinal cord stimulation system in patients with chronic, intractable pain.


  • All content Copyright © 2021 Westwick-Farrow Pty Ltd